Piramal TS tablets combine dihydroartemisinin and piperaquine phosphate in one tablet to leverage synergistic antimalarial action against resistant P. falciparum parasites.
Uses
Piramal TS is used to prevent and treat uncomplicated malaria infections caused by P. falciparum strains that are resistant to other antimalarials.
Benefits
Piramal TS tablets provide enhanced antimalarial potency via synergistic action of two compounds with different mechanisms targeting the malaria parasite lifecycle.
Mechanism of Action
Dihydroartemisinin generates toxic oxidative species that damage parasite cell components while piperaquine phosphate inhibits parasite heme detoxification activity and replication.
Dosage
The standard Piramal TS dosage is one tablet daily for three consecutive days taken orally. Dose can vary by bodyweight, age and other factors.
Side Effects
Nausea, vomiting, diarrhea, dizziness, neutropenia. Seek medical care if serious side effects occur.
Warnings
Not recommended for malaria prevention, severe malaria or in the first trimester of pregnancy without medical guidance.
Important Information
Inform your doctor about any other medications taken concurrently due to potential drug interactions. Complete full course for effectiveness.
Customer questions & answers
-
Can a breastfeeding mother take this drug please?
-
Q Can a breastfeeding mother take this drug please? answer nowAsked by Mary on April 11, 2024 7:33 pmAnswered by the admin
Yes, as long as the baby weigh more than 5 kg (11 lb)
why do i feel so dizzy and weak anytime i take this product
-
Q why do i feel so dizzy and weak anytime i take this product answer nowAsked by Precious Akan on February 2, 2024 6:47 pmAnswered by the admin
"Thank you, Precious Akan, for this question. Dizziness has been reported among people who take Pirimal TS; it is one of the most common side effects. If you find this disturbing, please let your pharmacist know. Here are other possible side effects: mild dizziness, vertigo, headache, nausea, vomiting, and abdominal discomfort. Reversible leucopenia was infrequently reported; dyspnea and palpitations were also reported but not further specified."
Reviews
There are no reviews yet.